Viking Therapeutics (VKTX) Share-based Compensation (2014 - 2026)
Viking Therapeutics' Share-based Compensation came in at $11.13 million for Q2 2026, down 17.8% from $13.55 million a year earlier but up 7.7% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Viking Therapeutics reported Share-based Compensation of $37.39 million, down 5.4% year-over-year; for FY2025, it was $40.82 million, up 37.4% from FY2024.
- Share-based Compensation has increased in each of the last eight years, with a five-year compound annual growth rate of 47.6% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $29.71 million in FY2024 (+77.4%), $16.75 million in FY2023 (+93.1%), $8.67 million in FY2022 (+42.2%) and $6.1 million in FY2021 (+4.8%).
- The five-year range for quarterly Share-based Compensation is $1.43 million (Q4 2021) to $13.55 million (Q2 2025).
- Year-over-year, Share-based Compensation increased in five of the last eight quarters, with growth averaging 34.9%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2023 (growth of 131.0%), and the weakest in Q3 2025 (a decline of 18.3%).
- Business Quant data shows VKTX's Share-based Compensation at $10.34 million (Q1 2026), $8.59 million (Q4 2025) and $7.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Viking Therapeutics | 2.99 Bn | 464.96 Mn | - | 11.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.13 Mn |
| Mar 31, 2026 | 10.34 Mn |
| Dec 31, 2025 | 8.59 Mn |
| Sep 30, 2025 | 7.34 Mn |
| Jun 30, 2025 | 13.55 Mn |
| Mar 31, 2025 | 11.35 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | 4.48 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 3.57 Mn |
| Dec 31, 2022 | 2.16 Mn |
| Sep 30, 2022 | 1.94 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.60 Mn |
API Access
Viking Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();